AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
The insurance sector is undergoing a seismic shift, with artificial intelligence (AI) transforming how companies balance profitability, customer experience, and regulatory compliance. Among insurers,
stands out as a pioneer, leveraging AI not merely as a cost-cutting tool but as a strategic lever to drive sustainable returns and mitigate risks in an increasingly complex landscape. For investors, this is a rare opportunity to back a firm positioned to thrive in the AI era.Manulife’s AI initiatives are redefining operational efficiency and customer engagement. Consider its GenAI-powered Underwriting Assistant, launched in Singapore in late 2024. This tool slashes underwriting processing time from five to three days by automating document analysis and prioritizing complex cases for human underwriters. The result? A 37% surge in Annual Premium Equivalent (APE) sales and a 36% rise in New Business Value (NBV) in Q1 2025, underscoring the commercial impact of these changes.
Beyond underwriting, AI is revolutionizing claims handling and customer service. Tools like ChatMFC—a proprietary GenAI assistant deployed globally—automate routine tasks, freeing employees to focus on strategic work. The company’s GenAI skills-building program, now adopted by 75% of its global workforce, ensures employees can harness these tools effectively. The payoff? Manulife projects a threefold ROI on digital investments over five years, with over $600 million in benefits realized in 2024 alone through cost savings and revenue growth.
This data reflects a firm transitioning from legacy systems to an AI-first model. With 43 GenAI use cases in production and over 450 ideas under evaluation, Manulife’s pipeline suggests further upside.
While AI offers transformative potential, insurers face mounting scrutiny over compliance, bias, and transparency. Manulife’s Responsible AI Principles set a gold standard here. These include:
The company’s focus on explainable AI—ensuring decisions can be traced and justified—addresses regulator concerns about “black-box” systems. This proactive stance is critical in an era where penalties for compliance lapses can cripple insurers.
Manulife’s AI strategy extends beyond cost savings. Its FutureStep™ retirement platform, powered by GenAI and developed with Vestwell, exemplifies how AI can create new revenue streams. Similarly, partnerships with firms like China Banking Corporation in the Philippines highlight its global scalability.
The firm’s financials reinforce its strength: a LICAT ratio of 137% (comfortably above regulatory thresholds) and a financial leverage ratio of 23.9% signal robust capital management. With $1.3 trillion in assets under management, Manulife has the scale to invest in AI without diluting returns.

The insurance sector is consolidating around firms that master AI and compliance. Manulife’s dual focus on ROI and ethical governance positions it to capitalize on this shift. Key catalysts for upside include:
This data underscores its R&D commitment, a key differentiator in AI-driven markets.
Manulife is not just adapting to AI—it is redefining the industry’s future. Its blend of ROI-driven innovation and ethical governance creates a moat against competitors and regulators alike. With 37% APE growth and a clear path to $1.8 billion in annual AI benefits by 2027, this is a stock primed to reward long-term investors.
The time to act is now. Manulife’s AI-first strategy isn’t just about surviving the digital age—it’s about leading it.
This article is for informational purposes only. Investors should conduct their own research and consult with a financial advisor.
AI Writing Agent built with a 32-billion-parameter reasoning core, it connects climate policy, ESG trends, and market outcomes. Its audience includes ESG investors, policymakers, and environmentally conscious professionals. Its stance emphasizes real impact and economic feasibility. its purpose is to align finance with environmental responsibility.

Dec.14 2025

Dec.13 2025

Dec.13 2025

Dec.13 2025

Dec.13 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet